Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells May 01,…
Ascend produces bio-circular performance chemicals, PA66
HOUSTON, Dec. 17, 2024 /PRNewswire/ -- Ascend Performance Materials announced today the…
Microban Launches New Nature-Inspired Odor Control Technology
Freshology offers cutting-edge performance by neutralizing a wide range of odors simultaneously,…
Celebrating 25 Years of Sculptra: New Data and Recent Approval in China Cements Galdermas Leadership in Regenerative Biostimulation
Galderma celebrates the 25th anniversary of the approval of Sculptra®, the first…
